Toll-like receptor expression and function in airway epithelial cells

Archivum Immunologiae et Therapiae Experimentalis

Volumn 53, Issue 5, 2005, Pages 418-427

  Greene, Catherine M ^a   McElvaney, Noel G ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

Airway epithelial cells; Inflammatory lung disease; Toll like receptors

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; BROPIRIMINE; DOUBLE STRANDED DNA; IMIQUIMOD; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LOXORIBINE; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANTIGEN RECOGNITION; ASTHMA; CELL TYPE; GENE EXPRESSION; GENE IDENTIFICATION; GRAM NEGATIVE INFECTION; HUMAN; INNATE IMMUNITY; MULTIGENE FAMILY; NONHUMAN; PNEUMONIA; POINT MUTATION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RESPIRATORY EPITHELIUM; REVIEW; STOP CODON; TRANSCRIPTION INITIATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, DIFFERENTIATION; ASTHMA; BRONCHI; CYSTIC FIBROSIS; EPITHELIAL CELLS; HUMANS; LIGANDS; MYELOID DIFFERENTIATION FACTOR 88; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; TRACHEA;

EID: 30944461373     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (95)

1. Adamo R., Sokol S., Soong G., Gomez M. I. and Prince A. (2004): Pseudomonas aeruginosa flagella activate airway epithelial cells through asialoGM1 and Toll-like receptor 2 as well as Toll-like receptor 5. Am. J. Respir. Cell Mol. Biol., 30, 627-634.
2. Agnese D. M., Galvano J. E., Hahm S. J., Coyle S. M., Corbett S. A., Galvano S. E. and Lowry S. F. (2002): Human Toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of Gram-negative infections. J. Infect. Dis., 186, 1522-1525.
3. Akira S. and Hemmi H. (2003): Recognition of pathogen-associated molecular patterns by TLR family. Immunol. Lett., 85, 85-95.
4. Alexopoulou L., Holt A. C., Medzhitov R. and Flavell R. A. (2001): Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature, 413, 732-738.
5. Armstrong L., Medford A. R., Uppington K. M., Robertson J., Witherden I. R., Tetley T. D. and Millar A. B. (2004): Expression of functional Toll-like receptor-2 and -4 on alveolar epithelial cells. Am. J. Respir. Cell Mol. Biol., 31, 241-245.
6. Bachar O., Adner M., Uddman R. and Cardell L. O. (2004): Toll-like receptor stimulation induces airway hyper-responsiveness to bradykinin, an effect mediated by JNK and NF-kappa B signaling pathways. Eur. J. Immunol., 34, 1196-1207.
7. Bartfai T., Behrens M. M., Gaidarova S., Pemberton J., Shivanyuk A. and Rebek J. Jr. (2003): A low molecular weight mimic of the Toll/IL-1 receptor/resistance domain inhibits IL-1 receptor-mediated responses. Proc. Natl. Acad. Sci. USA, 100, 7971-7976.
8. Basu S. and Fenton M. J. (2004): Toll-like receptors: function and roles in lung disease. Am. J. Physiol. Lung Cell Mol. Physiol., 286, L887-892.
9. Bauer S., Kirschning C. J., Hacker H., Redecke V., Hausmann S., Akira S., Wagner H. and Lipford G. B. (2001): Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl. Acad. Sci. USA, 98, 9237-9242.
10. Becker M. N., Diamond G., Verghese M. W. and Randell S. H. (2000): CD14-dependent lipopolysaccharide-induced beta-defensin-2 expression in human tracheobronchial epithelium. J. Biol. Chem., 275, 29731-29736.
11. Bell J. K., Mullen G. E., Leifer C. A., Mazzoni A., Davies D. R. and Segal D. M. (2003): Leucine-rich repeats and pathogen recognition in Toll-like receptors Trends Immunol., 24, 528-533.
12. Biragyn A., Ruffini P. A., Leifer C. A., Klyushnenkova E., Shakhov A., Chertov O., Shirakawa A. K., Farber J. M., Segal D. M., Oppenheim J. J. and Kwak L. W. (2002): Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science, 298, 1025-1029.
13. Bowie A. and O'Neill L. A. (2000): The interleukin-1 receptor//Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products. J. Leukoc. Biol., 67, 508-514.
14. Branger J., Leemans J. C., Florquin S., Weijer S., Speelman P. and Van Der Poll T. (2004): Toll-like receptor 4 plays a protective role in pulmonary tuberculosis in mice. Int. Immunol., 16, 509-516.
15. Braun-Fahrlander C., Riedler J., Herz U., Eder W., Waser M., Grize L., Maisch S., Carr D., Gerlach F., Bufe A., Lauener R. P., Schierl R., Renz H., Nowak D. and von Mutius E. (2002): Environmental exposure to endotoxin and its relation to asthma in school-age children. N. Engl. J. Med., 347, 869-877.
16. Child N. J., Yang I. A., Pulletz M. C., de Courcy-Golder K., Andrews A. L., Pappachan V. J. and Holloway J. W. (2003): Polymorphisms in Toll-like receptor 4 and the systemic inflammatory response syndrome. Biochem. Soc. Trans., 31, 652-653.
17. Chow J. C., Young D. W., Golenbock D. T., Christ W. J. and Gusovsky F. (1999): Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem., 274, 10689-10692.
18. Cook D. N., Pisetsky D. S. and Schwartz D. A. (2004): Toll-like receptors in the pathogenesis of human disease. Nat. Immunol., 5, 975-979.
19. Deng L., Wang C., Spencer E., Yang L., Braun A., You J., Slaughter C., Pickart C. and Chen Z. J. (2000): Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell, 103, 351-361.
20. Diebold S. S., Kaisho T., Hemmi H., Akira S. and Reis e Sousa C. (2004): Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science, 303, 1529-1531.
21. Droemann D., Goldmann T., Branscheid D., Clark R., Dalhoff K., Zabel P. and Vollmer E. (2003): Toll-like receptor 2 is expressed by alveolar epithelial cells type II and macrophages in the human lung. Histochem. Cell Biol., 119, 103-108.
22. Fitzgerald K. A., Palsson-McDermott E. M., Bowie A. G., Jefferies C. A., Mansell A. S., Brady G., Brint E., Dunne A., Gray P., Harte M. T., McMurray D., Smith D. E., Sims J. E., Bird T. A. and O'Neill L. A. (2001): Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature, 413, 78-83.
23. Fitzgerald K. A., Rowe D. C., Barnes B. J., Caffrey D. R., Visintin A., Latz E., Monks B., Pitha P. M. and Golenbock D. T. (2003): LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J. Exp. Med., 198, 1043-1055.
24. Gay N. J. and Keith F. J. (1991): Drosophila Toll and IL-1 receptor. Nature, 351, 355-356.
25. Gehring U., Bischof W., Fahlbusch B., Wichmann H. E. and Heinrich J. (2002): House dust endotoxin and allergic sensitization in children. Am. J. Respir. Crit. Care Med., 166, 939-944.
26. Gomi K., Kawasaki K., Kawai Y., Shiozaki M. and Nishijima M. (2002): Toll-like receptor 4-MD-2 complex mediates the signal transduction induced by flavolipin, an amino acid-containing lipid unique to Flavobacterium meningosepticum. J. Immunol., 168, 2939-2943.
27. Gon Y., Asai Y., Hashimoto S., Mizumura K., Jibiki I., Machino T., Ra C. and Horie T. (2004): A20 inhibits toll-like receptor 2- and 4-mediated interleukin-8 synthesis in airway epithelial cells. Am. J. Respir. Cell Mol. Biol., 31, 330-336.
28. Greene C. M., Carroll T. P., Smith S. G., Taggart C. C., Devaney J., Griffin S., O'Neill S. J. and McElvaney N. G. (2005): TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells. J. Immunol., 174, 1638-1646.
29. Guillot L., Balloy V., McCormack F. X., Golenbock D. T., Chignard M. and Si-Tahar M. (2002): Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4. J. Immunol., 168, 5989-5992.
30. Guillot L., Le Goffic R., Bloch S., Escriou N., Akira S., Chignard M. and Si-Tahar M. (2005): Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J. Biol. Chem., 280, 5571-5580.
31. Guillot L., Medjane S., Le-Barillec K., Balloy V., Danel C., Chignard M. and Si-Tahar M. (2004): Response of human pulmonary epithelial cells to lipopolysaccharide involves Toll-like receptor 4 (TLR4)-dependent signaling pathways: evidence for an intracellular compartmentalization of TLR4. J. Biol. Chem., 279, 2712-2718.
32. Hawn T. R., Verbon A., Lettinga K. D., Zhao L. P., Li S. S., Laws R. J., Skerrett S. J., Beutler B., Schroeder L., Nachman A., Ozinsky A., Smith K. D. and Aderem A. (2003): A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease. J. Exp. Med., 198, 1563-1572.
33. Hayashi F., Smith K. D., Ozinsky A., Hawn T. R., Yi E. C., Goodlett D. R., Eng J. K., Akira S., Underbill D. M. and Aderem A. (2001): The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature, 410, 1099-1103.
34. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., Lipford G., Wagner H. and Bauer S. (2004): Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science, 303, 1526-1529.
35. Hemmi H., Kaisho T., Takeuchi O., Sato S., Sanjo H., Hoshino K., Horiuchi T., Tomizawa H., Takeda K. and Akira S. (2002): Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol., 3, 196-200.
36. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K. and Akira S. (2000): A Toll-like receptor recognizes bacterial DNA. Nature, 408, 740-745.
37. Hershberg R. M. (2002): The epithelial cell cytoskeleton and intracellular trafficking. V. Polarized compartmentalization of antigen processing and Toll-like receptor signaling in intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol., 283, G833-839.
38. Hertz C. J., Wu Q., Porter E. M., Zhang Y. J., Weismuller K. H., Godowski P. J., Ganz T., Randell S. H. and Modlin R. L. (2003): Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human beta defensin-2. J. Immunol., 171, 6820-6826.
39. Homma T., Kato A., Hashimoto N., Batchelor J., Yoshikawa M., Imai S., Wakiguchi H., Saito H. and Matsumoto K. (2004): Corticosteroid and cytokines synergistically enhance Toll-like receptor 2 expression in respiratory epithelial cells. Am. J. Respir. Cell Mol. Biol., 31, 463-469.
40. Horng T., Barton G. M. and Medzhitov R. (2001): TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol., 2, 835-841.
41. Jia H. P., Kline J. N., Penisten A., Apicella M. A., Gioannini T. L., Weiss J. and McCray P. B. Jr. (2004): Endotoxin responsiveness of human airway epithelia is limited by low expression of MD-2. Am. J. Physiol. Lung Cell Mol. Physiol., 287, L428-437.
42. Jurk M., Heil F., Vollmer J., Schetter C., Krieg A. M., Wagner H., Lipford G. and Bauer S. (2002): Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat. Immunol., 3, 499.
43. Kawai T., Takeuchi O., Fujita T., Inoue J., Muhlradt P. F., Sato S., Hoshino K. and Akira S. (2001): Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol., 167, 5887-5894.
44. Krug A., Towarowski A., Britsch S., Rothenfusser S., Hornung V., Bals R., Giese T., Engelmann H., Endres S., Krieg A. M. and Hartmann G. (2001): Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur. J. Immunol., 31, 3026-3037.
45. Kurt-Jones E. A., Popova L., Kwinn L., Haynes L. M., Jones L. P., Tripp R. A., Walsh E. E., Freeman M. W., Golenbock D. T., Anderson L. J. and Finberg R. W. (2000): Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol., 1, 398-401.
46. Latz E., Schoenemeyer A., Visintin A., Fitzgerald K. A., Monks B. G., Knetter C. F., Lien E., Nilsen N. J., Espevik T. and Golenbock D. T. (2004): TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat. Immunol., 5, 190-198.
47. Lazarus R., Raby B. A., Lange C., Silverman E. K., Kwiatkowski D. J., Vercelli D., Klimecki W. J., Martinez F. D. and Weiss S. T. (2004): Toll-like receptor 10 genetic variation is associated with asthma in two independent samples. Am. J. Respir. Crit. Care Med., 170, 594-600.
48. Lemaitre B., Nicolas E., Michaut L., Reichhart J. M. and Hoffmann J. A. (1996): The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell, 86, 973-983.
49. Lorenz E., Mira J. P., Cornish K. L., Arbour N. C. and Schwartz D. A. (2000): A novel polymorphism in the Toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect. Immun., 68, 6398-6401.
50. Medzhitov R., Preston-Hurlburt P., Kopp E., Stadien A., Chen C., Ghosh S. and Janeway C. A. Jr. (1998): MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell, 2, 253-258.
51. Michel O., Ginanni R., Duchateau J., Vertongen F., Le Bon B. and Sergysels R. (1991): Domestic endotoxin exposure and clinical severity of asthma Clin. Exp. Allergy, 21, 441-448.
52. Michel O., Kips J., Duchateau J., Vertongen F., Robert L., Collet H., Pauwels R. and Sergysels R. (1996): Severity of asthma is related to endotoxin in house dust. Am. J. Respir. Crit. Care Med., 154, 1641-1646.
53. Monick M. M., Yarovinsky T. O., Powers L. S., Butler N. S., Carter A. B., Gudmundsson G. and Hunninghake G. W. (2003): Respiratory syncytial virus up-regulates TLR4 and sensitizes airway epithelial cells to endotoxin. J. Biol. Chem., 278, 53035-53044.
54. Muir A., Soong G., Sokol S., Reddy B., Gomez M. I., Van Heeckeren A. and Prince A. (2004): Toll-like receptors in normal and cystic fibrosis airway epithelial cells. Am. J. Respir. Cell Mol. Biol., 30, 777-783.
55. Nagai Y., Akashi S., Nagafuku M., Ogata M., Iwakura Y., Akira S., Kitamura T., Kosugi A., Kimoto M. and Miyake K. (2002): Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat. Immunol., 3, 667-672.
56. Ogus A. C., Yoldas B., Ozdemir T., Uguz A., Olcen S., Keser I., Coskun M., Cilli A. and Yegin O. (2004): The Arg753GLn polymorphism of the human Toll-like receptor 2 gene in tuberculosis disease. Eur. Respir. J., 23, 219-223.
57. Ohashi K., Burkart V., Flohe S. and Kolb H. (2000): Cutting edge: heat shock protein 60 is a putative endogenous ligand of the Toll-like receptor-4 complex. J. Immunol., 164, 558-561.
58. Okamura Y., Watari M., Jerud E. S., Young D. W., Ishizaka S. T., Rose J., Chow J. C. and Strauss J. F. 3rd. (2001): The extra domain A of fibronectin activates Toll-like receptor 4. J. Biol. Chem., 276, 10229-10233.
59. O'Neill L. A. (2002): Signal transduction pathways activated by the IL-1 receptor/Toll-like receptor superfamily. Curr. Top Microbiol. Immunol., 270, 47-61.
60. O'Neill L. A., Fitzgerald K. A. and Bowie A. G. (2003): The Toll-IL-1 receptor adaptor family grows to five members. Trends Immunol., 24, 286-290.
61. O'Neill L. A. and Greene C. (1998): Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J. Leukoc. Biol., 63, 650-657.
62. Oshiumi H., Matsumoto M., Funami K., Akazawa T. and Seya T. (2003): TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat. Immunol., 4, 161-167.
63. Oshiumi H., Sasai M., Shida K., Fujita T., Matsumoto M. and Seya T. (2003): TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to Toll-like receptor 4 TICAM-1 that induces interferon-beta. J. Biol. Chem., 278, 49751-49762.
64. Ozinsky A., Smith K. D., Hume D. and Underhill D. M. (2000): Co-operative induction of pro-inflammatory signaling by Toll-like receptors. J. Endotoxin Res., 6, 393-396.
65. Platz J., Beisswenger C., Dalpke A., Koczulla R., Pinkenburg O., Vogelmeier C. and Bals R. (2004): Microbial DNA induces a host defense reaction of human respiratory epithelial cells. J. Immunol., 173, 1219-1223.
66. Poltorak A., He X., Smirnova I., Liu M. Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B. and Beutler B. (1998): Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science, 282, 2085-2088.
67. Raby B. A., Klimecki W. T., Laprise C., Renaud Y., Faith J., Lemire M., Greenwood C., Weiland K. M., Lange C., Palmer L. J., Lazarus R., Vercelli D., Kwiatkowski D. J., Silverman E. K., Martinez F. D., Hudson T. J., and Weiss S. T. (2002): Polymorphisms in Toll-like receptor 4 are not associated with asthma or atopy-related phenotypes. Am. J. Respir. Crit. Care Med., 166, 1449-1456.
68. Rassa J. C., Meyers J. L., Zhang Y., Kudaravalli R. and Ross S. R. (2002): Murine retroviruses activate B cells via interaction with Toll-like receptor 4. Proc. Natl. Acad. Sci. USA, 99, 2281-2286.
69. Sasu S., LaVerda D., Qureshi N., Golenbock D. T. and Beasley D. (2001): Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via Toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation. Circ. Res., 89, 244-250.
70. Sato M., Sano H., Iwaki D., Kudo K., Konishi M., Takahashi H., Takahashi T., Imaizumi H., Asai Y. and Kuroki Y. (2003): Direct binding of Toll-like receptor 2 to zymosan, and zymosan-induced NF-kappa B activation and TNF-alpha secretion are down-regulated by lung collectin surfactant protein A. J. Immunol., 171, 417-425.
71. Schroder N. W., Pfeil D., Opitz B., Michelsen K. S., Amberger J., Zahringer U., Gobel U. B. and Schumann R. R. (2001): Activation of mitogen-activated protein kinases p42/44, p38, and stress-activated protein kinases in myelo-monocytic cells by Treponema lipoteichoic acid. J. Biol. Chem., 276, 9713-9719.
72. Schwartz D. A. (2002): TLR4 and LPS hyporesponsiveness in humans. Int. J. Hyg. Environ. Health, 205, 221-227.
73. Sha Q., Truong-Tran A. Q., Plitt J. R., Beck L. A. and Schleimer R. P. (2004): Activation of airway epithelial cells by Toll-like receptor agonists. Am. J. Respir. Cell Mol. Biol., 31, 358-364.
74. Sharma S., tenOever B. R., Grandvaux N., Zhou G. P., Lin R. and Hiscott J. (2003): Triggering the interferon antiviral response through an IKK-related pathway. Science, 300, 1148-1151.
75. Shim T. S., Turner O. C. and Orme I. M. (2003): Toll-like receptor 4 plays no role in susceptibility of mice to Mycobacterium tuberculosis infection, Tuberculosis, 83, 367-371.
76. Slack J. L., Schooley K., Bonnert T. P., Mitcham J. L., Qwarnstrom E. E., Sims J. E. and Dower S. K. (2000): Identification of two major sites in the type I interleukin-1 receptor cytoplasmic region responsible for coupling to pro-inflammatory signaling pathways. J. Biol. Chem., 275, 4670-4678.
77. Soong G., Reddy B., Sokol S., Adamo R. and Prince A. (2004): TLR2 is mobilized into an apical lipid raft receptor complex to signal infection in airway epithelial cells. J. Clin. Invest., 113, 1482-1489.
78. Suzuki N., Suzuki S., Duncan G. S., Millar D. G., Wada T., Mirtsos C., Takada H., Wakeham A., Itie A., Li S., Penninger J. M., Wesche H., Ohashi P. S., Mak T. W. and Yeh W. C. (2002): Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature, 416, 750-756.
79. Takeda K. and Akira S. (2004): TLR signaling pathways. Semin. Immunol., 16, 3-9.
80. Tantisira K., Klimecki W. T., Lazarus R., Palmer L. J., Raby B. A., Kwiatkowski D. J., Silverman E., Vercelli D., Martinez F. D. and Weiss S. T. (2004): Toll-like receptor 6 gene (TLR6): single-nucleotide polymorphism frequencies and preliminary association with the diagnosis of asthma. Genes Immun., 5, 343-346.
81. Taylor K. R., Trowbridge J. M., Rudisill J. A., Termeer C. C., Simon J. C. and Gallo R. L. (2004): Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J. Biol. Chem., 279, 17079-17084.
82. Vabulas R. M., Ahmad-Nejad P., Ghose S., Kirschning C. J., Issels R. D. and Wagner H. (2002): HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J. Biol. Chem., 277, 15107-15112.
83. Vabulas R. M., Braedel S., Hilf N., Singh-Jasuja H., Herter S., Ahmad-Nejad P., Kirschning C. J., Da Costa C., Rammensee H. G., Wagner H. and Schild H. (2002): The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway. J. Biol. Chem., 277, 20847-20853.
84. Walsh D. E., Greene C. M., Carroll T. P., Taggart C. C., Gallagher P. M., O'Neill S. J. and McElvaney N. G. (2001): Interleukin-8 up-regulation by neutrophil elastase is mediated by MyD88/IRAK/TRAF-6 in human bronchial epithelium. J. Biol. Chem., 276, 35494-35499.
85. Wang C., Deng L., Hong M., Akkaraju G. R., Inoue J. and Chen Z. J. (2001): TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature, 412, 346-351.
86. Wang X., Zhang Z., Louboutin J. P., Moser C., Weiner D. J. and Wilson J. M. (2003): Airway epithelia regulate expression of human beta-defensin 2 through Toll-like receptor 2. FASEB J., 17, 1727-1729.
87. Wenzel R. P. (1992): Anti-endotoxin monoclonal antibodies - a second look. N. Engl. J. Med., 326, 1151-1153.
88. Werner M., Topp R., Wimmer K., Richter K., Bischof W., Wjst M. and Heinrich J. (2003): TLR4 gene variants modify endotoxin effects on asthma. J. Allergy Clin. Immunol., 112, 323-330.
89. Wetzler L. M. (2003): The role of Toll-like receptor 2 in microbial disease and immunity. Vaccine, 21 (suppl. 2), S55-60.
90. Yamamoto M., Sato S., Hemmi H., Hoshino K., Kaisho T., Sanjo H., Takeuchi O., Sugiyama M., Okabe M., Takeda K. and Akira S. (2003): Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science, 301, 640-643.
91. Yamamoto M., Sato S., Hemmi H., Uematsu S., Hoshino K., Kaisho T., Takeuchi O., Takeda K. and Akira S. (2003): TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat. Immunol., 4, 1144-1150.
92. Yamamoto M., Sato S., Mori K., Hoshino K., Takeuchi O., Takeda K. and Akira S. (2002): Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J. Immunol., 169, 6668-6672.
93. Yamamoto M., Takeda K. and Akira S. (2004): TIR domain-containing adaptors define the specificity of TLR signaling. Mol. Immunol., 40, 861-868.
94. Yang I. A., Barton S. J., Rorke S., Cakebread J. A., Keith T. P., Clough J. B., Holgate S. T. and Holloway J. W. (2004): Toll-like receptor 4 polymorphism and severity of atopy in asthmatics. Genes Immun., 5, 41-45.
95. Zhang D., Zhang G., Hayden M. S., Greenblatt M. B., Bussey C., Flavell R. A. and Ghosh S. (2004): A Toll-like receptor that prevents infection by uropathogenic bacteria. Science, 303, 1522-1526.